Showing 32,721 - 32,740 results of 33,213 for search 'starost~', query time: 2.79s Refine Results
  1. 32721

    Clinical Effect on Early Rehabilitation Intervention of Patients after Coronary Artery bypass Grafting by Xin HE, Weiming ZHANG, Xin CHEN, Huijuan PAN, Yuanfeng SUN

    Published 2020-02-01
    “…The rehabilitation program started from the first 24 hours after surgery. The patients in the control group were given health education. …”
    Get full text
    Article
  2. 32722
  3. 32723

    Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients by Tara Seery, Lennie Sender, Omid Jafari, Frank Jones, Patricia Spilman, Sandeep B. Reddy, Patrick Soon-Shiong

    Published 2025-01-01
    “…Duration of spIND treatment and responses, for some patients including imaging and carbohydrate antigen 19-9 (CA19-9) levels, and OS from initial diagnosis and the start of spIND therapy were assessed.FindingsThe line/duration of spIND therapy was, for patients 1 through 5, respectively, second line/6.4 months, sixth line/3.5 months, third line/25.4 months, third line/7.4 months, and fourth line/23.2 months. …”
    Get full text
    Article
  4. 32724

    Digital Sensory Marketing Sebagai Upaya Meningkatkan Daya Saing Produk UMKM by Amelia Putri, Alwan Husni Ramdani, Aliya Nurul Fauziah, Muhammad Vickry Affryansyah, Gesha Fadhillah Ramdhan

    Published 2024-12-01
    “…First, marketing innovations are carried out, starting from content creation, introducing the product's unique selling point to consumers, and offering low prices. …”
    Get full text
    Article
  5. 32725

    Developing Guidelines for Conducting Stigma Research With Transgender and Nonbinary Individuals: Protocol for Creation of a Trauma-Informed Approach to Research by Augustus Klein, Sarit A Golub, Danielle Berke, Elijah Castle

    Published 2025-01-01
    “…ResultsThe study is funded by the National Institute of Mental Health starting in July 2022 and data collection began January 2023. …”
    Get full text
    Article
  6. 32726

    Efficacy and safety of everolimus for patients with focal cortical dysplasia type 2 by Se Hee Kim, Hoon‐Chul Kang, Yun Ho Roh, Jongsung Hahn, Kyung Lok Min, Seok‐Jin Lee, Donghwa Yang, Han Som Choi, Soyoung Park, Jeong Ho Lee, Sang‐Guk Lee, Se Hoon Kim, Min Jung Chang, Heung Dong Kim

    Published 2025-02-01
    “…Patients received everolimus or placebo in a blinded manner during core phase I, with crossover to the alternate treatment in core phase II. Everolimus dosage started at 4.5 mg/m2/day, targeting a serum level of 5–15 ng/mL. …”
    Get full text
    Article
  7. 32727

    An Ontology for Digital Medicine Outcomes: Development of the Digital Medicine Outcomes Value Set (DOVeS) by Benjamin Rosner, Matthew Horridge, Guillen Austria, Tiffany Lee, Andrew Auerbach

    Published 2025-02-01
    “…ObjectiveThis study aimed to develop, with inputs from industry, health care providers, payers, regulatory bodies, and patients through the Accelerated Digital Clinical Ecosystem (ADviCE) consortium, an ontology specific to DHT outcomes, the Digital medicine Outcomes Value Set (DOVeS), and to make this ontology publicly available and free to use. MethodsFrom a starting point of a 4-generation–deep hierarchical taxonomy developed by ADviCE, we developed DOVeS using the Web Ontology Language through the open-source ontology editor Protégé, and data from 185 vendors who had submitted structured product information to ADviCE. …”
    Get full text
    Article
  8. 32728

    Characterization of Cannabis usage in individuals with non-cancer chronic pain in the state of Maine using the Behavioral Risk Factor Surveillance System (BRFSS) by Rachel Bordonaro, Elizabeth N. Bean, Ling Cao

    Published 2025-01-01
    “…Conclusions Since the legalization of cannabis, Mainers have started to use it more frequently. High-frequency users are generally younger than non-users. …”
    Get full text
    Article
  9. 32729

    Comparison of Individualized Rescue Luteal Phase Support Strategies with Vaginal and Combined Vaginal & Subcutaneous Progesterone Administration in Artificial Frozen-Thawed Blastoc... by Secil Irem Arik Alpcetin, Onur Ince, Bengisu Akcay, Munire Funda Cevher Akdulum, Erhan Demirdag, Ahmet Erdem, Ahmet Erdem, Mehmet Erdem, Mehmet Erdem

    Published 2025-01-01
    “…The aim of this study is to investigate whether individualizing luteal support through rescue protocols in patients with low serum P4 levels improves pregnancy outcomes in HRT-FET cycles.Material and methodThis retrospective, single-center cohort analysis includes 1257 cycles involving 942 patients undergoing HRT-FET. Starting in 2019, we have assessed P4 levels before ET day and adjusted MVP doses when P4 levels were <10 ng/mL. …”
    Get full text
    Article
  10. 32730

    Deltopectoral approach without subscapularis detachment for reverse shoulder arthroplasty. Technique and results of a safe and reproducible subscapularis-sparing approach by Adrien Jacquot, MD, MSc, Thomas Cuinet, MD, Lisa Peduzzi, MD, Patrice Wong, MD, Marc-Olivier Gauci, MD, PhD, Julien Uhring, MD

    Published 2025-02-01
    “…In the absence of tendon suture, rehabilitation can be started immediately without motion restriction, allowing for a fast recovery and return to autonomy.…”
    Get full text
    Article
  11. 32731

    Lightweight Cryptographic Algorithms for Guessing Attack Protection in Complex Internet of Things Applications by Mohammad Kamrul Hasan, Muhammad Shafiq, Shayla Islam, Bishwajeet Pandey, Yousef A. Baker El-Ebiary, Nazmus Shaker Nafi, R. Ciro Rodriguez, Doris Esenarro Vargas

    Published 2021-01-01
    “…As the world keeps advancing, the need for automated interconnected devices has started to gain significance; to cater to the condition, a new concept Internet of Things (IoT) has been introduced that revolves around smart devicesʼ conception. …”
    Get full text
    Article
  12. 32732
  13. 32733

    Eosinophil is a predictor of severe immune-related adverse events induced by ipilimumab plus nivolumab therapy in patients with renal cell carcinoma: a retrospective multicenter co... by Yoshihiko Tasaki, Shuzo Hamamoto, Shimpei Yamashita, Junya Furukawa, Kazutoshi Fujita, Ryotaro Tomida, Makito Miyake, Noriyuki Ito, Hideto Iwamoto, Yoshihisa Mimura, Yosuke Sugiyama, Rei Unno, Atsushi Okada, Takahiro Yasui, Yoko Furukawa-Hibi

    Published 2025-01-01
    “…Median progression-free survival (mPFS), mPFS from the start of ipilimumab plus nivolumab therapy to second-line therapy (mPFS2), and median overall survival (mOS) were the shortest in the non-irAE group. …”
    Get full text
    Article
  14. 32734

    Cardiopulmonary Resuscitation in Interfacility Transport: An International Report Using the Ground Air Medical Quality in Transport (GAMUT) Database by Utpal S. Bhalala, Neeraj Srivastava, M. David Gothard, Michael T. Bigham

    Published 2020-01-01
    “…Examples include advanced airway presence, waveform capnography usage, average mobilization time from the start of referral until en route, 1st attempt intubation success rate, and DASH1A intubation success (definitive airway sans hypoxia/hypotension on 1st attempt). …”
    Get full text
    Article
  15. 32735

    "I feel good because I have saved their lives": Acceptability of assisted partner services among female index clients and male sexual partners in Kenya. by Brienna Naughton, Mercy Owuor, Beatrice Wamuti, David A Katz, Monisha Sharma, Wenjia Liu, Harison Lagat, Edward Kariithi, Mary Mugambi, Rose Bosire, Sarah Masyuko, Carey Farquhar, Bryan J Weiner

    Published 2023-01-01
    “…We investigated acceptability of APS when integrated into HIV services in Kenya.<h4>Methods</h4>Starting in May 2018, APS was implemented in 31 health facilities in Kisumu and Homa Bay counties in western Kenya. …”
    Get full text
    Article
  16. 32736

    Improvement of survival and development of Pacific white shrimp Litopenaeus vannamei larvae by feeding taurine enriched rotifers by Dedi Jusadi, Syarifah Ruchyani, Ing Mokoginta, Julie Ekasari

    Published 2015-03-01
    “…White shrimp larvae at sixth naupliar stage were reared in 12 units of 500 L fibre glass tanks with a stocking density of 125 ind/L. Starting from zoea two stage (Z-2), the larva was provided with rotifers with different taurine enrichment concentration according to the treatments, i.e. 0 mg/L enrichment medium (A), 25 mg/L (B), 50 mg/L(C), and 100 mg/L (D). …”
    Get full text
    Article
  17. 32737

    A Framework for Analyzing Absorptive Capacity Using Social Network Analysis (Case Study: Sharif University Innovation Ecosystem) by Mahdi Mohammadi, Mahdi Elyasi, Azadeh Savehshemshaki

    Published 2024-04-01
    “…Methods Sharif University of Technology is a pioneer in establishing a cluster platform for start-ups and accelerators. The growth of innovation clusters is a current policy focus in many countries. …”
    Get full text
    Article
  18. 32738

    Analysis of risk factors of feeding intolerance in ICU patients with enteral nutrition (ICU肠内营养患者喂养不耐受的危险因素分析) by LI Peiyao (李佩瑶), WANG Yue (王玥), ZHANG Yang (张洋), ZHANG Jinjuan (张金娟), JIA Dan (贾丹)

    Published 2024-10-01
    “…Results The daily dosage of enteral nutrition preparations (OR=1. 007), time to start enteral nutrition (OR=7. 361), mechanical ventilation (OR=25. 643), vasoactive drugs (OR=19. 049), antibiotics (OR=23. 267), length of hospitalization (OR=1. 522), and acid-inhibiting drugs (OR=0. 149) were risk factors of feeding intolerance, and probiotics(OR=0. 016)was a protective factor of feeding intolerance. …”
    Get full text
    Article
  19. 32739

    Evolocumab safety and efficacy in hypercholesteremia patients with or without diabetes: a retrospective real-world analysis by Sultan Ibrahim Alraddadi, Hind Almodaimegh, Abdullah Kharbosh, Hadeel Alharbi, Ahmed Ibrahim Fathelrahman, Mona Yaser Alsheikh, Lama Alfehaid

    Published 2025-01-01
    “…All patients who had been on maximally tolerated statin and ezetimibe therapy for at least 4 months before starting evolocumab were included. The included participants were then divided into diabetic and non-diabetic groups and assessed for evolocumab’s efficacy and safety. …”
    Get full text
    Article
  20. 32740

    Impact of periprocedural factors on revascularization success and good clinical outcomes in anterior circulation stroke patients treated with mechanical thrombectomy by M. Kurminas, A. Berūkštis, N. Misonis, A. E. Tamošiūnas, D. Jatužis

    Published 2019-09-01
    “…Trends towards better clinical outcomes were observed in younger patients and in those who started treatment with MTE within 4.5 hours of onset of stroke symptoms. …”
    Get full text
    Article